ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors.

Valentine M Macaulay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.